Voranigo 10 mg (Vorasidenib Tablet) 10mg

VORASIDENIB 10 mg tablets are prescribed for glioma treatment. This oral therapy targets specific genetic mutations in cancer cells. Store at room temperature and keep out of reach of children. Always follow your healthcare provider’s instructions.

Strength

10mg

Pack Size

30s

Storage

15-25°

Manufacturer / TM Owner

SERVIER PHARMACEUTICALS LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VORASIDENIB 10 mg tablets are used to treat glioma, a type of brain tumor. It works by blocking abnormal signals that cause cancer cells to grow. Patients with specific genetic mutations may benefit from this therapy. Always consult a doctor to determine suitability.

Side Effects

Common effects of VORASIDENIB 10 mg include mild nausea, fatigue, and changes in liver function tests. Some patients may experience skin reactions or digestive discomfort. These effects are typically monitored during treatment. Report any persistent symptoms to your healthcare provider.

Precautions & Warnings

Keep VORASIDENIB 10 mg tablets in their original packaging at room temperature. Avoid exposure to moisture or direct sunlight. Do not crush, split, or chew the tablets unless instructed. Inform your doctor about all medications and supplements you are taking before starting this treatment.

Avoid Interactions

VORASIDENIB 10 mg may interact with strong CYP3A4 inhibitors or inducers, altering its effectiveness. Grapefruit products and certain antibiotics can also affect how the drug works. Alcohol and other medications metabolized by the liver should be used with caution. Always discuss potential interactions with your healthcare provider.

Frequently Asked Questions

VORASIDENIB 10 mg is used to treat glioma, a type of brain tumor, in patients with specific genetic mutations.

Store VORASIDENIB 10 mg tablets at room temperature, between 15–25°C, in their original packaging.

Consult your doctor before taking VORASIDENIB 10 mg with other medications to avoid potential interactions.

Common side effects may include nausea, fatigue, and changes in liver function tests.

Availability may vary by region; consult a licensed pharmacy or healthcare provider for online purchase options.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.